Aehr Test Systems (NASDAQ: AEHR) Sees Director Share Sales Amid Strong Stock Performance and Semiconductor Industry Growth

• Aehr Test Systems (NASDAQ: AEHR) delivered over 200% return in 2026, outperforming the market.
• Two company directors recently sold shares, totaling over $2.10 million, while the stock trades near its 52-week high.
• Despite mixed quarterly results, a record backlog indicates strong future revenue growth for the semiconductor solutions provider.

Aehr Test Systems (NASDAQ: AEHR), a leading provider of test and burn-in solutions within the semiconductor industry, has demonstrated exceptional stock performance. The company's stock was a top market performer in 2026, delivering a remarkable return of over 200% during the year, as highlighted by MarketBeat. This places Aehr Test Systems in a small group of stocks within the Russell 3000 Index with such significant gains, underscoring its position as a notable semiconductor stock.

Against this backdrop of strong stock performance, recent insider trading activity has emerged. On Monday, April 13, 2026, Director DANESH FARIBA executed a director share sale, selling 7,000 shares of Common Stock at a price of $71.49 per share. Following this transaction, DANESH FARIBA now directly owns 13,143 shares of Aehr Test Systems.

This transaction follows another recent sale by a different company insider. On Thursday, April 9th, Director Rhea Posedel sold 30,000 shares at an average price of $70.00 each, as highlighted by Defense World. This significant sale totaled $2.10 million, and the director now owns 426,979 shares in Aehr Test Systems.

These insider sales are occurring as Aehr Test Systems' stock trades near its 52-week high of $74.44, representing a significant increase from its 52-week low of $7.71. The company's market capitalization, which is the total value of all its shares, stands at approximately $2.25 billion. The stock has also experienced a substantial trading volume of over 3.33 million shares, indicating high investor interest in this semiconductor stock analysis.

Aehr Test Systems' recent quarterly results were mixed, as highlighted by Seeking Alpha. While revenues came in below expectations with continued cash use, a surge in system orders has driven Aehr Test Systems' backlog to a new all-time high. This robust backlog suggests strong revenue growth is anticipated for the 2027 fiscal year, providing a positive semiconductor industry outlook for the company.